https://www.aclweb.org/adminwiki/index.php?action=history&feed=atom&title=2025Q3_Reports%3A_SIGBioMed 2026-04-27T20:36:04Z Revision history for this page on the wiki MediaWiki 1.43.6 https://www.aclweb.org/adminwiki/index.php?title=2025Q3_Reports:_SIGBioMed&diff=76386&oldid=prev 2025-06-06T20:48:16Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 20:48, 6 June 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l3">Line 3:</td> <td colspan="2" class="diff-lineno">Line 3:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>SIGBIOMED is ACL&#039;s special interest group for Biomedical Natural Language Processing that encompasses all sublanguages related to health, ranging from biology to clinical language in all registers and health literacy levels.   </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>SIGBIOMED is ACL&#039;s special interest group for Biomedical Natural Language Processing that encompasses all sublanguages related to health, ranging from biology to clinical language in all registers and health literacy levels.   </div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Membership currently stands at <del style="font-weight: bold; text-decoration: none;">121</del>, up from <del style="font-weight: bold; text-decoration: none;">39 initial members</del>.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Membership currently stands at <ins style="font-weight: bold; text-decoration: none;">238</ins>, up from <ins style="font-weight: bold; text-decoration: none;">224 in 2024</ins>.</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>ORGANIZATION  </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>ORGANIZATION  </div></td></tr> </table>

Dina https://www.aclweb.org/adminwiki/index.php?title=2025Q3_Reports:_SIGBioMed&diff=76383&oldid=prev 2025-06-06T20:42:44Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 20:42, 6 June 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l22">Line 22:</td> <td colspan="2" class="diff-lineno">Line 22:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>WEBSITE and MAILING LIST</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>WEBSITE and MAILING LIST</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>-----------------</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>-----------------</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>We have a working <del style="font-weight: bold; text-decoration: none;">[</del>https://aclweb.org/aclwiki/SIGBIOMED<del style="font-weight: bold; text-decoration: none;">] </del>that lists upcoming  </div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>We have a working <ins style="font-weight: bold; text-decoration: none;">site </ins>https://aclweb.org/aclwiki/SIGBIOMED that lists upcoming  </div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>events of interest to our members and links to BioNLP proceedings.  </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>events of interest to our members and links to BioNLP proceedings.  </div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> </table>

Dina https://www.aclweb.org/adminwiki/index.php?title=2025Q3_Reports:_SIGBioMed&diff=76381&oldid=prev 2025-06-06T02:37:37Z

<p>Created page with &quot;MEMBERSHIP ---------- SIGBIOMED is ACL&#039;s special interest group for Biomedical Natural Language Processing that encompasses all sublanguages related to health, ranging from bi...&quot;</p> <p><b>New page</b></p><div>MEMBERSHIP<br /> ----------<br /> SIGBIOMED is ACL&#039;s special interest group for Biomedical Natural Language Processing that encompasses all sublanguages related to health, ranging from biology to clinical language in all registers and health literacy levels. <br /> <br /> Membership currently stands at 121, up from 39 initial members.<br /> <br /> ORGANIZATION <br /> --------<br /> <br /> The Chair, Vice-Chair and the Secretary are completing their 3-year term. The Nominating committee issued a call for nominees; voting will take place in July 2025 and the results will be announced at the BioNLP 2025 workshop. <br /> In compliance with the BioNLP constitution, the elected officers will serve for 3 years. <br /> <br /> WORKSHOP<br /> --------<br /> We held two workshops in 2024: BioNLP 2024 @ ACL 2024 that attracted about 80 attendees and the first workshop on patient-oriented language processing CL4Health at LREC-COLING 2024. CL4Health was met with great enthusiasm and the attendees unanimously voted for continuing this specialized workshop. CL4Health 2025 @NAACL attracted good number of strong submissions and had good attendance. <br /> <br /> FUNDS<br /> ----------------<br /> Sophia Ananiadou received a small grant from Chen Institute: https://brand.cheninstitute.org/ The grant will cover the invited speaker registration and prizes for students representing most interesting approaches in the four shared tasks held in conjunction with BioNLP 2025. <br /> <br /> <br /> WEBSITE and MAILING LIST<br /> -----------------<br /> We have a working [https://aclweb.org/aclwiki/SIGBIOMED] that lists upcoming <br /> events of interest to our members and links to BioNLP proceedings. <br /> <br /> We use the BioNLP and AMIA nlp-sig mailing lists for announcements and discussions.<br /> <br /> Links to our Google groups:<br /> https://groups.google.com/g/sigbiomed<br /> https://groups.google.com/forum/#!forum/bionlpinfo</div>

Dina